Mdivi-1

Catalog No.S7162

Mdivi-1 is a selective cell-permeable inhibitor of mitochondrial division DRP1 (dynamin-related GTPase) and mitochondrial division Dynamin I (Dnm1) with IC50 of 1-10 μM.

Price Stock Quantity  
USD 147 In stock
USD 297 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Mdivi-1 Chemical Structure

Mdivi-1 Chemical Structure
Molecular Weight: 353.22

Validation & Quality Control

Quality Control & MSDS

Product Information

  • Compare Dynamin Inhibitors
    Compare Dynamin Products

Product Description

Biological Activity

Description Mdivi-1 is a selective cell-permeable inhibitor of mitochondrial division DRP1 (dynamin-related GTPase) and mitochondrial division Dynamin I (Dnm1) with IC50 of 1-10 μM.
Targets Dynamin1 [1]
IC50 1 μM-10 μM
In vitro Mdivi-1 is a cell-permeable quinazolinone compound that inhibits yeast (Dnm1) and mammalian (Drp1) division DRPs (dynamin-related GTPases) and effectively induces mitochondrial fusion into net-like structures in a reversible manner. Cell-free studies indicate that mdivi-1 blocks Dnm1 ATPase activity (IC50<10 μM) and self-assembly by an allosteric modulation-based mechanism. Mdivi-1 is shown to effectively suppress STS- as well as C8-Bid-induced MOMP (Mitochondrial Outer Membrane Permeabilization) in HeLa cultures and in cell-free murine liver mitochondria preparations, respectively, as assessed by cytochrome C release. In cells, mdivi-1 retards apoptosis by inhibiting mitochondrial outer membrane permeabilization. In principle, mivi-1 represents a class of therapeutics for stroke, myocardial infarction, and neurodegenerative diseases. [1]
In vivo Drp1 and GFAP protein expression is significantly increased in the early neurodegenerative events of ischemic mouse retina. Mdivi-1 treatment blocks apoptotic cell death in ischemic retina, and significantly increases RGC survival at 2 weeks after ischemia. In the normal mouse retina, Drp1 is expressed in the ganglion cell layer (GCL) as well as the inner plexiform layer, the inner nuclear layer (INL), and the outer plexiform layer (OPL). In the GCL, Drp1 immunoreactivity is strong in RGCs. While Drp1 protein expression is increased in the GCL of vehicle-treated ischemic retina at 12 hours. Mdivi-1 treatment does not change this increase of Drp1 protein expression but significantly decreased GFAP protein expression. [2]
Features The first selective inhibitor of mitochondrial division dynamins.

Protocol(Only for Reference)

Kinase Assay:

[1]

GTP hydrolysis For determination of the kinetic parameters, GTPase assays are carried out in 25 mM HEPES, 25 mM PIPES, pH 7, 150 mM NaCl, 30 mM imidazole, pH 7.4, 7.5 mM KCl, 5 mM MgCl2, 1 mM phospho(enol)pyruvate (PEP), 20 U/mL pyruvate kinase/lactate dehydrogenase, 4% dimethyl sulfoxide (DMSO), and 600 μM NADH. Chemical inhibitor and GTP concentrations are varied, as specified. GTPase assay reactions are started by addition of approximately 10 μg of purified protein, in freezing buffer, to the GTPase assay reaction buffer containing the small molecule.

Animal Study:

[2]

Animal Models C57BL/6 mice
Formulation dimethyl sulfoxide [DMSO]
Dosages 50 mg/kg
Administration IP injection

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)0.020.151.80.40.0810
Body Surface Area (m2)0.0070.0250.150.050.020.5
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)
1

References

[1] Cassidy-Stone A, et al. Dev Cell, 2008, 14(2), 193-204.

[2] Park SW, et al. Invest Ophthalmol Vis Sci, 2011, 52(5), 2837-2843.

Chemical Information

Download Mdivi-1 SDF
Molecular Weight (MW) 353.22
Formula

C15H10Cl2N2O2S

CAS No. 338967-87-6
Storage 3 years -20℃powder
2 years -80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 70 mg/mL (198.17 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
In vivo 5% DMSO+40% PEG 300+ddH2O 7mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name 4(1H)-Quinazolinone, 3-(2,4-dichloro-5-methoxyphenyl)-2,3-dihydro-2-thioxo-

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Dynamin Products

Recently Viewed Items

Tags: buy Mdivi-1 | Mdivi-1 supplier | purchase Mdivi-1 | Mdivi-1 cost | Mdivi-1 manufacturer | order Mdivi-1 | Mdivi-1 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us